CONTACT
+91 80 2808 2808
info@biocon.com

Press Releases

Biocon  /  News – Posts  /  Press Releases

Biocon Earnings Q4FY20 Revenue Up 6% at Rs 1,644 Cr; EBITDA Down 11% at Rs 382 Cr; Net Profit Down 42% at Rs 123 Cr
  • Thu, 14-May-2020
  • Posted by: BIOCON
No Comments

Biocon and Mylan Launch Fulphila®, Biosimilar Pegfilgrastim, in Canada
  • Tue, 28-Apr-2020
  • Posted by: BIOCON
No Comments

Kiran Mazumdar-Shaw Recognized among World’s Top 20 Inspirational Leaders in Biopharmaceuticals in The Medicine Maker ‘Power List 2020’
  • Mon, 27-Apr-2020
  • Posted by: BIOCON
No Comments

Biocon and Mylan Launch Fulphila®, Biosimilar Pegfilgrastim, in Australia
  • Tue, 14-Apr-2020
  • Posted by: BIOCON
No Comments

Biocon & Biocon Biologics Ensuring Manufacturing of Life-Saving Medicines for Patients, Partners and Customers
  • Fri, 27-Mar-2020
  • Posted by: BIOCON
No Comments

Biocon & Mylan Win Patent Litigation Asserted by Sanofi for Insulin Glargine Device Patent in U.S.
  • Wed, 11-Mar-2020
  • Posted by: BIOCON
No Comments

U.S. FDA Accepts Biologics License Application (BLA) for Mylan and Biocon’s Proposed Biosimilar Bevacizumab for Review
  • Mon, 09-Mar-2020
  • Posted by: BIOCON
No Comments

Kiran Mazumdar-Shaw Named EY Entrepreneur of the Year India 2019
  • Thu, 20-Feb-2020
  • Posted by: BIOCON
No Comments

Biocon Q3FY20 Earnings Revenue at Rs 1,784 Cr, Up 14%; EBITDA at Rs 480 Cr, Up 18%; Net Profit (before exceptional item) at Rs 225 Cr, Up 6%
  • Thu, 23-Jan-2020
  • Posted by: BIOCON
No Comments

Kiran Mazumdar-Shaw Honoured with Order of Australia, Australia’s Highest Civilian Honour
  • Sat, 18-Jan-2020
  • Posted by: BIOCON
No Comments

Report adverse event/ side effects and/or product complaints for Biocon products.


Click here to report adverse event/side effects/product complaints and/or submit medical queries for Biocon Biologics Limited & BBL Affiliate products.

Click here to report adverse event/side effects/product complaints and/or post medical queries for Biocon Limited, Biocon Pharma Limited, Biocon Pharma Inc., Biocon Pharma UK Limited, Biocon Pharma Malta Ltd and Biocon FZ LLC products.





* Safe Harbour | Privacy Policy | Terms of Use © 2024, Biocon. All Rights Reserved
Share
Leaving the Biocon site!

You are now leaving the Biocon website for a Biocon affiliate site or third party site that is solely responsible for its content, including its compliance with guidelines applicable in certain geographies. Links to Biocon affiliate sites and third party sites are provided as a resource to our visitors and may not be governed by the same regulatory requirements applicable to this site and unaffiliated third party sites are subject to their own terms and data protection notices and practices. Moreover, if their third party site is subject to other country laws, regulatory requirements, data protection requirements or medical practices may differ between countries and the information provided therein may not be suitable for use in your country.

Agree >>